STEINMAN LAWRENCE 4
4 · Pasithea Therapeutics Corp. · Filed Jun 6, 2023
Insider Transaction Report
Form 4
STEINMAN LAWRENCE
Director
Transactions
- Purchase
Common Stock
2023-06-02$0.43/sh+30,000$12,930→ 1,327,174 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.38 to $0.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.